Andrea DiFabio

General Counsel at XENON PHARMACEUTICALS INC.

Net worth: 440 688 $ as of 30/06/2026

57 year

91 connections

Health Technology

Consumer Services

Commercial Services

Profile

Andrea DiFabio is Secretary & Chief Legal Officer at Xenon Pharmaceuticals, Inc. since 2022.
Former roles include Secretary, Chief Legal & Administrative Officer at Repertoire Immune Medicines, Inc. from 2020 to 2022; Secretary, Chief Legal Officer & Executive VP at Bioverativ, Inc. from 2016 to 2018; Chief Research & Business Development Counsel at Biogen, Inc. from 2006 to 2017; Chief Legal Officer at Codiak BioSciences, Inc.; Vice President & Deputy General Counsel at PAREXEL International Corp.; and Director-Northeast Chapter at the Association of Corporate Counsel.
Education includes undergraduate studies at Boston University and graduate studies at Northeastern University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
XENON PHARMACEUTICALS INC. 0.01%	07/04/2026	7,301 ( 0.01% )	440 688 $	30/06/2026

Andrea DiFabio active positions

Companies	Position	Start
XENON PHARMACEUTICALS INC.	General Counsel	07/11/2022

All active positions of Andrea DiFabio

Former positions of Andrea DiFabio

Companies	Position	End
Repertoire Immune Medicines, Inc. Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer	Chief Administrative Officer	01/10/2022
BIOVERATIV INC	General Counsel	01/06/2018
BIOGEN INC.	Corporate Officer/Principal	01/02/2017
CODIAK BIOSCIENCES	General Counsel	-
Association of Corporate Counsel Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services Operates as a business professionals association	Corporate Officer/Principal	-

See the detail of Andrea DiFabio's experience

Training of Andrea DiFabio

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrea DiFabio's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
PAREXEL International Corp. PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xenon Pharmaceuticals, Inc. Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders	Health Technology
Northeastern University Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Association of Corporate Counsel Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services Operates as a business professionals association	Commercial Services
Codiak BioSciences, Inc. Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics	Health Technology
Bioverativ, Inc. Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders	Health Technology
Repertoire Immune Medicines, Inc. Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer	Health Technology